MNKD
NASDAQ · Biotechnology
Mannkind Corp
$3.92
+0.16 (+4.26%)
Open$3.90
Previous Close$3.76
Day High$4.10
Day Low$3.80
52W High$6.51
52W Low$2.23
Volume—
Avg Volume3.24M
Market Cap1.21B
P/E Ratio—
EPS$-0.14
SectorBiotechnology
Analyst Ratings
Strong Buy
14 analysts
Price Target
+706.4% upside
Current
$3.92
$3.92
Target
$31.61
$31.61
$20.51
$31.61 avg
$34.61
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 342.65M | 225.76M | 248.98M |
| Net Income | 5.77M | 3.42M | -49,454,944 |
| Profit Margin | 1.7% | 1.6% | -19.9% |
| EBITDA | 42.01M | 26.29M | -82,218,351 |
| Free Cash Flow | — | — | -29,596,680 |
| Rev Growth | +51.8% | +51.8% | +22.2% |
| Debt/Equity | 1.64 | 1.64 | 1.00 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $291.31 | +1.07% | 49.3 | 509.50B |
| AMGN | Amgen Inc | $460.42 | +0.03% | 26.5 | 248.84B |
| GILD | Gilead Sciences Inc | $166.89 | -0.41% | — | 208.28B |
| VRTX | Vertex Pharmaceuticals Inc | $547.09 | +0.85% | 34.5 | 137.12B |
| REGN | Regeneron Pharmaceuticals | $904.35 | +0.16% | 19.4 | 93.39B |
| ALNY | Alnylam Pharmaceuticals Inc | $155.94 | -0.46% | 7.7 | 20.98B |